Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,107 | -39,696 | -32,575 | -26,141 | -22,044 |
| Depreciation Amortization | 888 | 4,577 | 3,568 | 2,483 | 1,113 |
| Accounts receivable | -75 | 2,812 | 1,953 | 173 | 3,000 |
| Other Working Capital | -2,013 | -5,892 | -1,888 | -2,722 | -1,155 |
| Other Operating Activity | -1,437 | -5,284 | -549 | 3,507 | 5,399 |
| Operating Cash Flow | $-11,744 | $-43,483 | $-29,491 | $-22,700 | $-13,687 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,429 | -25,568 | -159 | -1,707 | 1,178 |
| PPE Investments | -218 | 1,604 | 1,485 | 1,384 | -103 |
| Investing Cash Flow | $2,211 | $-23,964 | $1,326 | $-323 | $1,075 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 46,960 | 4,189 | N/A | N/A |
| Other Financing Activity | -4 | -3,787 | -3,782 | -3,782 | 0 |
| Financing Cash Flow | $-4 | $43,173 | $407 | $-3,782 | $N/A |
| Beginning Cash Position | 14,555 | 38,829 | 38,829 | 38,829 | 38,829 |
| End Cash Position | 5,018 | 14,555 | 11,071 | 12,024 | 26,217 |
| Net Cash Flow | $-9,537 | $-24,274 | $-27,758 | $-26,805 | $-12,612 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,744 | -43,483 | -29,491 | -22,700 | -13,687 |
| Capital Expenditure | -218 | -130 | -105 | -103 | -103 |
| Free Cash Flow | -11,962 | -43,613 | -29,596 | -22,803 | -13,790 |